Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 138505-25-6 | MDL No. : | MFCD02257437 |
Formula : | C10H11BrO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | GRLHVQABEZCTRD-UHFFFAOYSA-N |
M.W : | 243.10 | Pubchem ID : | 819973 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.3 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 55.64 |
TPSA : | 26.3 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.35 cm/s |
Log Po/w (iLOGP) : | 2.52 |
Log Po/w (XLOGP3) : | 3.43 |
Log Po/w (WLOGP) : | 3.05 |
Log Po/w (MLOGP) : | 2.44 |
Log Po/w (SILICOS-IT) : | 3.18 |
Consensus Log Po/w : | 2.92 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.65 |
Solubility : | 0.0542 mg/ml ; 0.000223 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.66 |
Solubility : | 0.0528 mg/ml ; 0.000217 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.77 |
Solubility : | 0.0415 mg/ml ; 0.000171 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.69 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | With potassium carbonate; caesium carbonate In <i>N</i>-methyl-acetamide | Step A: Synthesis of 5-bromo-2-isopropoxybenzaldehyde AX. To a suspension of potassium carbonate (34.4 g, 249 mmol) and cesium carbonate (16.2 g, 50 mmol) in dimethylformamide were added 5-bromosalicaldehyde (25.0 g, 124 mmol) and 2-iodopropane (25.0 mL, 249 mmol). The suspension was stirred at room temperature overnight, then at 70° C. for 4 hrs. The volatiles were removed, and the residue was partitioned between methyl t-butylether and water. The aqueous layer was extracted with methyl t-butylether and the combined organic phases were washed with water, sodium hydroxide, and brine, and then dried over magnesium sulfate. Concentration to dryness afforded compound AX (30.0 g) as a pale yellow oil in 99percent yield. 1H NMR (CDCl3, 400 MHz): δ 1.40 (d, J=6.3 Hz, 6H), 4.65 (sept., J=6.0 Hz, 1H), 6.89 (d, J=9.0 Hz, 1H), 7.59 (dd, J=9.0 and 2.7 Hz, 1H), 7.91 (d, J=2.7 Hz, 1H), 10.39 (s, 1H). |
99% | With potassium carbonate; caesium carbonate In N,N-dimethyl-formamide at 20 - 70℃; for 4 h; | To a suspension of potassium carbonate (34.4 g, 249 mmol) and cesium carbonate (16.2 g, 50 mmol) in dimethylformamide were added 5-bromosalicaldehyde (25.0 g, 124 mmol) and 2-iodopropane (25.0 mL, 249 mmol). The suspension was stirred at room temperature overnight, then at 70° C. for 4 hrs. The volatiles were removed, and the residue was partitioned between methyl t-butylether and water. The aqueous layer was extracted with methyl t-butylether and the combined organic phases were washed with water, sodium hydroxide, and brine, and then dried over magnesium sulfate. Concentration to dryness afforded compound AX (30.0 g) as a pale yellow oil in 99percent yield. 1H NMR (CDCl3, 400 MHz): δ (ppm) 1.40 (d, J=6.3 Hz, 6H), 4.65 (sept., J=6.0 Hz, 1H), 6.89 (d, J=9.0 Hz, 1H), 7.59 (dd, J=9.0 and 2.7 Hz, 1H), 7.91 (d, J=2.7 Hz, 1H), 10.39 (s, 1H). |
98% | With potassium carbonate In N,N-dimethyl-formamide at 60℃; for 0.5 h; Inert atmosphere | To a solution of 5-bromo-2-hydroxybenzaldehyde 3 (600 mg, 3.0mmol) and 2-iodopropane (1.4 ml, 15 mmol) in dry-DMF wasadded K2CO3 (3.2 g, 24 mmol). The mixture was heated at 60 Cunder N2 in oil bath. The mixture was stirred for 30 min. The excessK2CO3 was quenched with 1 M aq. HCl. After the addition 1 M aq.HCl, extracted with ethyl acetate and washed with brine. Theorganic layer was dried over Na2SO4, filtered and concentrated. The residue waspurified by column chromatography on silica gel (hexane / AcOEt = 20 : 1 ) to give5-bromo-2-isopropoxybenzaldehyde (712.6 mg, 98percent) as a colorless oil. 1H NMR (270MHz, CDCl3) δ 1.40 (d. J = 5.94 Hz, 6H), 4.58-4.71 (m, 1H), 6.89 (d, J = 9.2 Hz, 1H),7.59 (d, J = 8.6 Hz, 1H), 7.91 (s, 1H), 10.40 (s, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
82% | With N-Bromosuccinimide In N,N-dimethyl-formamide at 20℃; | To a stirred solution of 2- isopropoxybenzaldehyde (0.51 g, 3.1 mmol), in DMF (10 ml) NBS (0.55 g, 3.1 mmol) was added and the reaction mixture was stirred overnight at room temperature. The reaction was quenched with NaHCO3 solution and extracted in EtOAc (50 ml). The organic layer was washed with H2O, dried over MgSO4 and filtered. The filtrate was evaporated to dryness to give the title compound (0.62 g, 82percent) as light yellow oil. 1 H-NMR (CDCI3) 10.37 (s, 1 H); 7.89 (d, 1 H, J = 2.52 Hz); 7.55 (dd, 1 H, J = 8.85, 2.58 Hz); 6.87 (d, 1 H, J = 8.88 Hz); 4.67 - 4.58 (m, 1 H); 1.35 (d, 6H, J = 6.03 Hz). |
[ 162147-12-8 ]
2-Bromo-5-isopropoxybenzaldehyde
Similarity: 0.88
[ 955931-76-7 ]
4-(4-Bromophenethoxy)benzaldehyde
Similarity: 0.88
[ 24589-89-7 ]
2-(4-Bromo-2-formylphenoxy)acetic acid
Similarity: 0.86
[ 162147-12-8 ]
2-Bromo-5-isopropoxybenzaldehyde
Similarity: 0.88
[ 955931-76-7 ]
4-(4-Bromophenethoxy)benzaldehyde
Similarity: 0.88
[ 24589-89-7 ]
2-(4-Bromo-2-formylphenoxy)acetic acid
Similarity: 0.86
[ 162147-12-8 ]
2-Bromo-5-isopropoxybenzaldehyde
Similarity: 0.88
[ 955931-76-7 ]
4-(4-Bromophenethoxy)benzaldehyde
Similarity: 0.88
[ 24589-89-7 ]
2-(4-Bromo-2-formylphenoxy)acetic acid
Similarity: 0.86
[ 162147-12-8 ]
2-Bromo-5-isopropoxybenzaldehyde
Similarity: 0.88
[ 955931-76-7 ]
4-(4-Bromophenethoxy)benzaldehyde
Similarity: 0.88
[ 24589-89-7 ]
2-(4-Bromo-2-formylphenoxy)acetic acid
Similarity: 0.86